BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17413002)

  • 1. Medulloblastomas derived from Cxcr6 mutant mice respond to treatment with a smoothened inhibitor.
    Sasai K; Romer JT; Kimura H; Eberhart DE; Rice DS; Curran T
    Cancer Res; 2007 Apr; 67(8):3871-7. PubMed ID: 17413002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shh pathway activity is down-regulated in cultured medulloblastoma cells: implications for preclinical studies.
    Sasai K; Romer JT; Lee Y; Finkelstein D; Fuller C; McKinnon PJ; Curran T
    Cancer Res; 2006 Apr; 66(8):4215-22. PubMed ID: 16618744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.
    Romer JT; Kimura H; Magdaleno S; Sasai K; Fuller C; Baines H; Connelly M; Stewart CF; Gould S; Rubin LL; Curran T
    Cancer Cell; 2004 Sep; 6(3):229-40. PubMed ID: 15380514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gli1 is important for medulloblastoma formation in Ptc1+/- mice.
    Kimura H; Stephen D; Joyner A; Curran T
    Oncogene; 2005 Jun; 24(25):4026-36. PubMed ID: 15806168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
    Kool M; Jones DT; Jäger N; Northcott PA; Pugh TJ; Hovestadt V; Piro RM; Esparza LA; Markant SL; Remke M; Milde T; Bourdeaut F; Ryzhova M; Sturm D; Pfaff E; Stark S; Hutter S; Seker-Cin H; Johann P; Bender S; Schmidt C; Rausch T; Shih D; Reimand J; Sieber L; Wittmann A; Linke L; Witt H; Weber UD; Zapatka M; König R; Beroukhim R; Bergthold G; van Sluis P; Volckmann R; Koster J; Versteeg R; Schmidt S; Wolf S; Lawerenz C; Bartholomae CC; von Kalle C; Unterberg A; Herold-Mende C; Hofer S; Kulozik AE; von Deimling A; Scheurlen W; Felsberg J; Reifenberger G; Hasselblatt M; Crawford JR; Grant GA; Jabado N; Perry A; Cowdrey C; Croul S; Zadeh G; Korbel JO; Doz F; Delattre O; Bader GD; McCabe MG; Collins VP; Kieran MW; Cho YJ; Pomeroy SL; Witt O; Brors B; Taylor MD; Schüller U; Korshunov A; Eils R; Wechsler-Reya RJ; Lichter P; Pfister SM;
    Cancer Cell; 2014 Mar; 25(3):393-405. PubMed ID: 24651015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of suppressor-of-fused function promotes tumorigenesis.
    Lee Y; Kawagoe R; Sasai K; Li Y; Russell HR; Curran T; McKinnon PJ
    Oncogene; 2007 Sep; 26(44):6442-7. PubMed ID: 17452975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists.
    Chenna V; Hu C; Pramanik D; Aftab BT; Karikari C; Campbell NR; Hong SM; Zhao M; Rudek MA; Khan SR; Rudin CM; Maitra A
    Mol Cancer Ther; 2012 Jan; 11(1):165-73. PubMed ID: 22027695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier.
    Rohner A; Spilker ME; Lam JL; Pascual B; Bartkowski D; Li QJ; Yang AH; Stevens G; Xu M; Wells PA; Planken S; Nair S; Sun S
    Mol Cancer Ther; 2012 Jan; 11(1):57-65. PubMed ID: 22084163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice.
    Lelievre V; Seksenyan A; Nobuta H; Yong WH; Chhith S; Niewiadomski P; Cohen JR; Dong H; Flores A; Liau LM; Kornblum HI; Scott MP; Waschek JA
    Dev Biol; 2008 Jan; 313(1):359-70. PubMed ID: 18036580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.
    Yauch RL; Dijkgraaf GJ; Alicke B; Januario T; Ahn CP; Holcomb T; Pujara K; Stinson J; Callahan CA; Tang T; Bazan JF; Kan Z; Seshagiri S; Hann CL; Gould SE; Low JA; Rudin CM; de Sauvage FJ
    Science; 2009 Oct; 326(5952):572-4. PubMed ID: 19726788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.
    Zindy F; Uziel T; Ayrault O; Calabrese C; Valentine M; Rehg JE; Gilbertson RJ; Sherr CJ; Roussel MF
    Cancer Res; 2007 Mar; 67(6):2676-84. PubMed ID: 17363588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-hit model for progression of medulloblastoma preneoplasia in Patched heterozygous mice.
    Pazzaglia S; Tanori M; Mancuso M; Gessi M; Pasquali E; Leonardi S; Oliva MA; Rebessi S; Di Majo V; Covelli V; Giangaspero F; Saran A
    Oncogene; 2006 Sep; 25(40):5575-80. PubMed ID: 16636673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma.
    Shahi MH; Afzal M; Sinha S; Eberhart CG; Rey JA; Fan X; Castresana JS
    BMC Cancer; 2010 Nov; 10():614. PubMed ID: 21059263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule modulators of the Sonic Hedgehog signaling pathway.
    Stanton BZ; Peng LF
    Mol Biosyst; 2010 Jan; 6(1):44-54. PubMed ID: 20024066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma.
    Zurawel RH; Allen C; Chiappa S; Cato W; Biegel J; Cogen P; de Sauvage F; Raffel C
    Genes Chromosomes Cancer; 2000 Jan; 27(1):44-51. PubMed ID: 10564585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.
    Vaillant C; Valdivieso P; Nuciforo S; Kool M; Schwarzentruber-Schauerte A; Méreau H; Cabuy E; Lobrinus JA; Pfister S; Zuniga A; Frank S; Zeller R
    PLoS One; 2015; 10(4):e0124870. PubMed ID: 25901736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistance.
    Dijkgraaf GJ; Alicke B; Weinmann L; Januario T; West K; Modrusan Z; Burdick D; Goldsmith R; Robarge K; Sutherlin D; Scales SJ; Gould SE; Yauch RL; de Sauvage FJ
    Cancer Res; 2011 Jan; 71(2):435-44. PubMed ID: 21123452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Patched-1 and Smoothened in testicular meiotic and post-meiotic cells.
    Morales CR; Fox A; El-Alfy M; Ni X; Argraves WS
    Microsc Res Tech; 2009 Nov; 72(11):809-15. PubMed ID: 19484749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.
    Ayrault O; Zindy F; Rehg J; Sherr CJ; Roussel MF
    Mol Cancer Res; 2009 Jan; 7(1):33-40. PubMed ID: 19147535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched.
    Wetmore C; Eberhart DE; Curran T
    Cancer Res; 2000 Apr; 60(8):2239-46. PubMed ID: 10786690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.